Abstract:Background: Since December, 2019, the outbreak of COVID-19, epidemiological and clinical characteristics of patients with COVID-19 have been reported to be a feature of normal white blood cell count, lymphopenia and eosinopenia. But there has been no systemic study on eosinophil count reduction and its implication in patients with COVID-19.Methods: In this retrospective, single centre study, we included all available inpatients of COVID-19 with nucleic acid test positive confirmation and corticosteroid-naïve when admission in Renmin Hospital of Wuhan University (Wuhan, China) from Jan 28 to Mar 26, 2020. Demographic, clinical, treatment, and laboratory data were extracted from electronic medical records and dynamic changes of % eosinophil count was compared between survivors and non-survivors, patients of general type or severe type and those of critical type. We described the general distribution of eosinophil count in patients of COVID-19 and correlated LOER (length of eosinophil count return) with LOS (length of hospital stay).Findings: 453 patients were included in this study, of whom 45 died in hospital and 408 were discharged, which were classified as general type, severe type and critical type. Eosinophil count at illness onset fell below 0.4% (the lower normal limit) in 302 (66.7%) of the patients and differed between survivors and non-survivors, the general type or severe type and the critical type. LOER correlated with LOS significantly (r=0·14, 95%CI: 0·04 to 0·24, p<0·01). Eosinophil count returned to normal much quicker in general type or severe type than in critical type, but returned very slowly or even could not return for non-survivals comparing to survivals.Interpretation: Peripheral blood eosinophil count was markedly reduced in majority of the patients infected with SARS-CoV-2 at their illness onset. LOER correlates to LOS. A persistent low eosinophil count maybe a predictor of poor prognosis.Funding Statement: None.Declaration of Interests: The authors declare no competing interests.Ethics Approval Statement: Ethic approval was obtained from the Research Ethics Committee of the Renmin Hospital of Wuhan University, Wuhan, China (approval number: WDRY2020-K041). The Research Ethics Committee waived the requirement of informed consent before the study started because of the urgent need to collect epidemiological and clinical data. We analyzed all the data anonymously.

The Dynamic Changes of Eosinophils and Its Potential Predictive Value in Patients with COVID-19

Patients of COVID-19 may benefit from sustained Lopinavir-combined regimen and the increase of Eosinophil may predict the outcome of COVID-19 progression

The role of peripheral blood eosinophil counts in COVID‐19 patients

Characteristics of peripheral white blood cells in COVID-19 patients revealed by a retrospective cohort study

Blood Eosinophils Matter in Post-COVID-19 Pneumonia

Analysis of Blood Index Characteristics in COVID-19 Patients and Their Associations with Different Outcomes

Expression of eosinophil in peripheral blood of patients with COVID‐19 and its clinical significance

COPD patients with high blood eosinophil counts exhibit a lower rate of omicron infection and milder post‐infection symptoms

Analysis of the Dynamic Relationship Between Immune Profiles and the Clinical Features of Patients with COVID-19

Lymphopenia predicted illness severity and recovery in patients with COVID-19: A single-center, retrospective study

Decreased eosinophil counts and elevated lactate dehydrogenase predict severe COVID-19 in patients with underlying chronic airway diseases

Normalization of eosinophil count is predictive of oxygen weaning over the course of COVID-19 infection among hospitalized adults during the first wave of 2020 pandemic

Dynamic changes in peripheral blood lymphocyte subsets in adult patients with COVID-19

The Association of Blood Eosinophils and Neutrophils Expressing Eosinophilic Surface Markers with the Severity and Outcome of COVID-19

Modeling undesirable factors in efficiency evaluation

Effect of blood analysis and immune function on the prognosis of patients with COVID-19

The clinical course and its correlated immune status in COVID-19 pneumonia

Hematologic changes predict clinical outcome in recovered patients with COVID-19

Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients

Potential Factors for Prediction of Disease Severity of COVID-19 Patients

Longitudinal changes of inflammatory parameters and their correlation with disease severity and outcomes in patients with COVID-19 from Wuhan, China